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Description
A 64-year-old man presented at the emergency 
department for lipothymia, nausea and palpita-
tions for a few days duration. He was diagnosed 
with HIV infection 10 years ago. He never was 
compliant with his antiretroviral therapy (ART).
Pertinent physical findings included tachycardia 
and tachypnoea. Laboratory work-up revealed 
elevated troponin 0.30 ng/mL, elevated brain natri-
uretic peptide (PBNP) 4435 pg/mL and elevated creat-
inine 1.8 mg/dL with urea in normal range (40 mg/dL). 
Blood exams revealed CD4+ T cell count of 47 cells/
µL with HIV RNA copies of 213 025/mL. The chest 
CT scan showed thickening of the lateral slope of the 
right cardiac cavities and atrioventricular septum, with 
involvement of the pericardial cavity; three pericardiac 
ganglia close to the right atrium, the largest with 16 mm 
(figure 1A). The pelvic CT scan showed kidneys with 
small hyperdensal, peripheral foci, predominantly on 
the right (figure 1B). Transthoracic echocardiography 
demonstrated heterogeneous ecodense mass centred 
on the lateral wall of the right atrium, extending infe-
riorly to the atrioventricular sulcus and basal free wall 
of the right ventricle, with invasion of the posterior 
tricuspid valve leaflet (7.3×4.4×4.8 mm), extending 
to the pericardial space. A cardiac MRI revealed a 
second intramyocardial nodular lesion in the apical 
septal segment (figure 2A,B). Biopsy of the right kidney 
was performed and histological findings revealed 
Burkitt’s lymphoma. The patient started ART and 
chemotherapy (CTX) (Berlin-Frankfurt-Munster 95 
protocol) associated to rituximab. In the fourth CTX 
cycle, there were no signs of the disease on the kidney 
and there was a significant decrease in the intracardiac 
masses.
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Figure 1 Chest CT scan demonstrating thickening 
of the lateral slope of the right cardiac cavities and 
atrioventricular septum. Intracardiac mass involving the 
pericardial cavity; three pericardiac ganglia close to the 
right atrium, the largest with 16 mm.
Figure 2 Cardiac MRI-cine four-chamber long-axis 
sequence showing an intracardiac mass visible on the 
right cardiac cavities and a second intramyocardial 
nodular lesion with 3×2.2 mm of dimension in the apical 
septal segment.
Learning points
 ► Within the group of non-Hodgkin’s lymphomas 
(NHL), Burkitt’s lymphoma is one of the most 
aggressive subtypes. This is a rare disease in 
the general population, accounting for about 
1% of all NHL. However, in patients with 
HIV, even with the advent of ART, their risk 
increases 200-fold.1
 ► Cardiac involvement of disseminated 
lymphoma is common; however, primary 
cardiac lymphoma is extremely rare. In fact, 
from data collected, <30 cases of intracardiac 
mass secondary to Burkitt’s lymphoma are 
reported.2 We must bear in mind that the 
cardiac symptoms are non-specific and can 
often be underestimated, leading to diagnostic 
errors. Given the aggressiveness of the cardiac 
tumour, its rapid progression can become 
life-threatening in a short time. Thus, any delay 
in diagnosis or treatment can decrease the 
chance of survival. We highlight the importance 
of early diagnosis and emphasise the presence 
of exuberant imaging alterations.
 ► There are multiple chemotherapy (CTX) 
protocols to treatment of adults’ Burkitt’s 
NHLs and usually an adaptation of children 
schemas. In our case, the patient was 
treated with Berlin-Frankfurt-Munster 
95 protocol that includes association of 
anthracyclin, alkylanting agents and high 
dose of antimetabolites drugs. There is now 
evidence of benefit of rituximab association 
to CTX in non-randomised and randomised 
trials and patients with Burkitt’s lymphomas 
not associated to immunodeficiency and 
to B-cell NHLs in context of patients with 
immunodeficiency.3
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